FI91156B - Förfarande för framställning av terapeutiskt användbara neplanocinderivat - Google Patents
Förfarande för framställning av terapeutiskt användbara neplanocinderivat Download PDFInfo
- Publication number
- FI91156B FI91156B FI893003A FI893003A FI91156B FI 91156 B FI91156 B FI 91156B FI 893003 A FI893003 A FI 893003A FI 893003 A FI893003 A FI 893003A FI 91156 B FI91156 B FI 91156B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- compound
- effective
- compounds
- cyclohexylidenedioxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Claims (3)
1. Förfarande för framställning av nya terapeutiskt användbara neplanosinderivat med formeln I och farmaceu-5 tiskt godtagbara salter därav, nh2 x Z' N
10 HC H—\ V 15 ^......' H OH OH 1 vilken formel X är halogen, kännetecknat 20 därav, att en förening med formeln nh2
25 N. Ä X // ^ N HC N S/
30 H-H / \_|/h OB A 2® 35 D där X betecknar samma som ovan, O är en skyddad hydroxi- Q grupp och A2 är en skyddad hydroxigrupp, behandlas med en syra; 5 och, om sä önskas, omvandlas den erhälinä föreningen tili ett farmaceutiskt godtagbart sait.
2. Förfarande enligt patentkravet 1, känne-t e c k n a t därav, att man framställer en förening med formeln I, där X är fluor. 10
3. Förfarande enligt patentkravet 1, känne- t e c k n a t därav, att man framställer en förening med formeln I, där X är klor. Il
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20924588A | 1988-06-20 | 1988-06-20 | |
| US20924588 | 1988-06-20 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI893003A0 FI893003A0 (sv) | 1989-06-19 |
| FI893003A FI893003A (sv) | 1989-12-21 |
| FI91156B true FI91156B (sv) | 1994-02-15 |
| FI91156C FI91156C (sv) | 1994-05-25 |
Family
ID=22777970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI893003A FI91156C (sv) | 1988-06-20 | 1989-06-19 | Förfarande för framställning av terapeutiskt användbara neplanocinderivat |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0347852B1 (sv) |
| JP (1) | JP2967998B2 (sv) |
| KR (1) | KR0139808B1 (sv) |
| CN (1) | CN1040031A (sv) |
| AR (1) | AR244688A1 (sv) |
| AT (1) | ATE126800T1 (sv) |
| AU (1) | AU612854B2 (sv) |
| CA (1) | CA1339646C (sv) |
| DE (1) | DE68923913T2 (sv) |
| DK (1) | DK301789A (sv) |
| ES (1) | ES2078904T3 (sv) |
| FI (1) | FI91156C (sv) |
| GR (1) | GR3017794T3 (sv) |
| HU (1) | HUT50194A (sv) |
| IE (1) | IE66980B1 (sv) |
| IL (1) | IL90639A (sv) |
| NO (1) | NO168108C (sv) |
| NZ (1) | NZ229596A (sv) |
| PT (1) | PT90903B (sv) |
| ZA (1) | ZA894534B (sv) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5521162A (en) * | 1987-08-26 | 1996-05-28 | Merrell Pharmaceuticals Inc. | Aristeromycin analogues of 4',5'-didehydro-5'-fluoro-adenosine and methods of treating neoplastic and viral disease conditions |
| GB8815265D0 (en) * | 1988-06-27 | 1988-08-03 | Wellcome Found | Therapeutic nucleosides |
| HU204843B (en) * | 1988-09-27 | 1992-02-28 | Merrell Dow Pharma | Process for producing 2'-halogen-methylidene adenosine derivatives and pharmaceutical compositions comprising same |
| JPH0421682A (ja) * | 1990-05-11 | 1992-01-24 | Asahi Chem Ind Co Ltd | ２―フルオロネプラノシンａおよびその製造法 |
| GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
| US5399580A (en) * | 1993-03-08 | 1995-03-21 | Burroughs Wellcome Co. | Therapeutic nucleosides-uses |
| GB9600142D0 (en) * | 1996-01-05 | 1996-03-06 | Wellcome Found | Chemical compounds |
| ATE310524T1 (de) * | 1999-06-09 | 2005-12-15 | Anticancer Inc | Modulatoren der methylierung zur kontrolle von bakterieller virulenz |
| SG182849A1 (en) | 2003-04-25 | 2012-08-30 | Gilead Sciences Inc | Antiviral phosphonate analogs |
| PT2258376T (pt) * | 2004-07-27 | 2019-05-31 | Gilead Sciences Inc | Análogos fosfonatados de compostos inibidores do vih |
| CN102089318B (zh) | 2008-07-08 | 2014-05-21 | 吉里德科学公司 | Hiv抑制剂化合物的盐 |
| JP2012503651A (ja) * | 2008-09-26 | 2012-02-09 | エージェンシー フォー サイエンス，テクノロジー アンド リサーチ | ３−デアザネプラノシン誘導体 |
| ES2969496T3 (es) | 2017-08-01 | 2024-05-20 | Gilead Sciences Inc | Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2- il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU192741B (en) * | 1978-05-25 | 1987-07-28 | Toyo Jozo Kk | Process for producing new neplanocin antibiotics |
| DE3148363A1 (de) * | 1980-12-12 | 1982-09-16 | Toyo Jozo K.K., Shizuoka | Neplanocin a-derivate |
| FR2580283B1 (fr) * | 1985-04-15 | 1989-11-24 | Toyo Jozo Kk | Nouveau conjugue nucleoside-phospholipide |
| DE3778626D1 (de) * | 1986-09-27 | 1992-06-04 | Toyo Jozo Kk | Nukleosid-phospholipid-konjugat. |
-
1989
- 1989-06-14 ZA ZA894534A patent/ZA894534B/xx unknown
- 1989-06-16 AU AU36517/89A patent/AU612854B2/en not_active Ceased
- 1989-06-16 NZ NZ229596A patent/NZ229596A/en unknown
- 1989-06-16 AR AR89314191A patent/AR244688A1/es active
- 1989-06-16 IL IL90639A patent/IL90639A/xx not_active IP Right Cessation
- 1989-06-19 DK DK301789A patent/DK301789A/da not_active Application Discontinuation
- 1989-06-19 HU HU893137A patent/HUT50194A/hu unknown
- 1989-06-19 NO NO892543A patent/NO168108C/no not_active IP Right Cessation
- 1989-06-19 IE IE198689A patent/IE66980B1/en not_active IP Right Cessation
- 1989-06-19 PT PT90903A patent/PT90903B/pt not_active IP Right Cessation
- 1989-06-19 FI FI893003A patent/FI91156C/sv not_active IP Right Cessation
- 1989-06-20 EP EP89111230A patent/EP0347852B1/en not_active Expired - Lifetime
- 1989-06-20 CA CA000603455A patent/CA1339646C/en not_active Expired - Fee Related
- 1989-06-20 JP JP1155992A patent/JP2967998B2/ja not_active Expired - Fee Related
- 1989-06-20 KR KR1019890008457A patent/KR0139808B1/ko not_active IP Right Cessation
- 1989-06-20 AT AT89111230T patent/ATE126800T1/de not_active IP Right Cessation
- 1989-06-20 DE DE68923913T patent/DE68923913T2/de not_active Expired - Fee Related
- 1989-06-20 CN CN89104094A patent/CN1040031A/zh active Pending
- 1989-06-20 ES ES89111230T patent/ES2078904T3/es not_active Expired - Lifetime
-
1995
- 1995-10-18 GR GR950402897T patent/GR3017794T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ229596A (en) | 1990-12-21 |
| FI893003A (sv) | 1989-12-21 |
| ATE126800T1 (de) | 1995-09-15 |
| EP0347852A3 (en) | 1991-09-11 |
| PT90903A (pt) | 1989-12-29 |
| AU612854B2 (en) | 1991-07-18 |
| EP0347852A2 (en) | 1989-12-27 |
| CN1040031A (zh) | 1990-02-28 |
| DK301789A (da) | 1989-12-21 |
| AU3651789A (en) | 1989-12-21 |
| JP2967998B2 (ja) | 1999-10-25 |
| KR0139808B1 (ko) | 1998-06-01 |
| GR3017794T3 (en) | 1996-01-31 |
| DE68923913T2 (de) | 1996-01-11 |
| ZA894534B (en) | 1990-03-28 |
| DE68923913D1 (de) | 1995-09-28 |
| KR910000734A (ko) | 1991-01-30 |
| NO892543D0 (no) | 1989-06-19 |
| IL90639A (en) | 1992-12-01 |
| CA1339646C (en) | 1998-01-27 |
| EP0347852B1 (en) | 1995-08-23 |
| HUT50194A (en) | 1989-12-28 |
| AR244688A1 (es) | 1993-11-30 |
| NO892543L (no) | 1989-12-21 |
| PT90903B (pt) | 1994-12-30 |
| IE891986L (en) | 1989-12-20 |
| FI91156C (sv) | 1994-05-25 |
| DK301789D0 (da) | 1989-06-19 |
| NO168108C (no) | 1992-01-15 |
| IL90639A0 (en) | 1990-01-18 |
| JPH0240369A (ja) | 1990-02-09 |
| ES2078904T3 (es) | 1996-01-01 |
| NO168108B (no) | 1991-10-07 |
| FI893003A0 (sv) | 1989-06-19 |
| IE66980B1 (en) | 1996-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7399754B2 (en) | N2-quinoline or isoquinoline substituted purine derivatives | |
| FI91156B (sv) | Förfarande för framställning av terapeutiskt användbara neplanocinderivat | |
| EP3365323B1 (en) | Salts of tetracyclines | |
| JPH06505725A (ja) | ５−フルオロ−２’−デオキシ−３’−チアシチジンのｂ型肝炎治療への使用 | |
| DK169657B1 (da) | Anvendelse af visse uracilnucleosider til fremstilling af et lægemiddel mod adenovirusinfektioner samt oftalmiske præparater indeholdende sådanne uracilnucleosider | |
| AU613660B2 (en) | Novel aristeromycin/adenosine derivatives | |
| JPH0826037B2 (ja) | 生理活性物質ｋ−２５２の誘導体 | |
| PT90080B (pt) | Processo para a preparacao de novos derivados acetilenicos, ciano e alenicos de aristeromicina/adenosina | |
| EP0328111B1 (en) | Cancer cell metastasis inhibitors | |
| EP2021334B1 (en) | Synthesis and uses of pyroglutamic acid derivatives | |
| JP2968002B2 (ja) | 新規な２′―ハロメチリデン、２′―エテニリデン及び２′―エチニルアデノシン誘導体類 | |
| JP2789228B2 (ja) | 新規なｓ―アデノシルメチオニンデカルボキシラーゼ阻害剤 | |
| US5250545A (en) | Cancer cell metastasis inhibitor methods | |
| US4997925A (en) | 5'-deoxy-5',5'-dihalo adenosines and purine analogues | |
| CN113105391B (zh) | 一种具有镇痛活性的高乌甲素衍生物及其制备方法和应用 | |
| RU2200157C2 (ru) | Пиридинкарбоксамидины, способ их получения и фармацевтическая композиция на их основе | |
| US20220098169A1 (en) | Antiviral agents | |
| WO1998018807A1 (fr) | Derives de l'erythromycine a | |
| JP2004502780A (ja) | アデノシン化合物及びそれを含む医薬組成物 | |
| CN116589518A (zh) | 一种新型的胞苷衍生物及其药物组合物和用途 | |
| AU689443B2 (en) | Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same | |
| JPH10338690A (ja) | アスコルビン酸誘導体およびその用途 | |
| JP2001002647A (ja) | ベンゾフェナンスリジニウム誘導体 | |
| JPH05194518A (ja) | ６−メルカプトプリン誘導体及びその製法 | |
| JPH03163079A (ja) | キサンチン誘導体、それらを有効成分とする気管支拡張剤及び脳機能改善剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed |
Owner name: MERRELL DOW PHARMACEUTICALS INC. |